Scholars@Duke
Search form
Search
Advanced Search
Support
Index
Subscribe to Announcements
Menu
Search
Home
People
Schools / Institutes
Research
About
Home
People
Schools / Institutes
Research
Ph III study to evaluate the safety of ALN-TTR02 in TTR-Medicated Polyneuropathy
Administered By
Duke Cancer Institute
Awarded By
Alnylam Pharmaceuticals
Contributors
Kang, Yubin
Principal Investigator
Start/End
November 1, 2014 - August 2, 2018